This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Congenital myopathies present diagnostic challenges in infants and young children since clinical findings alone are rarely distinguishing among the different diseases. Traditional workup for nonprogressive congenital neuromuscular weakness with normal creatine phosphokinase often leads the clinician toward muscle biopsy, hoping for a clear cut pathologic diagnosis. However, much of the time the initial biopsy in young children reveals nonspecific features including fiber type disproportion, type predominance, rarely uniform type 1 fibers, both cores and rods, or even less specific findings. The clinician is thus faced with presenting a best guess to the family, and the option of repeat biopsy at a future date which may or may not reveal a specific diagnosis. Muscle MRI provides further supportive information if a specific pattern of signal abnormality is revealed but usually requires sedation in this age group and rarely leads to a confident diagnosis. Of greater consequence is …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Alert Me
Recommended articles
Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation
Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene
An unusual ryanodine receptor 1 (RYR1) phenotype
Expanding genotype/phenotype of neuromuscular diseases by comprehensive target capture/NGS